Find a Provider

David M. Mintzer, MD

David M. Mintzer, MD Physician

Associate Director, CREP Program
Chief, Section of Hematology-Oncology, Pennsylvania Hospital
Director, Palliative Care
Clinical Professor of Medicine

Dr. Mintzer is a Penn Medicine employed physician.

About Dr. D Mintzer

Recognized annually in Philadelphia Magazine's Top Docs issue from 2004 through 2015

Recognized by Best Doctors in America 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, 2013-2014

Recognized by Suburban Life magazine's "Top Physicians 2010" issue

Recognized in America's Top Doctors, 2008, 2010, 2011-14

Clinical Specialties


  • Medicine
    • Hematology
    • Medical Oncology

Programs & Services:

  • Cancer
    • Anal Cancer
    • Bone Marrow Transplant and Stem Cell Transplant Program
    • Brain Metastasis
    • Brain Tumors
    • Breast Cancer
    • Colon Cancer
    • Gastrointestinal Carcinoid Tumor
    • Leukemia
    • Liver Cancer
    • Lung Cancer
    • Oropharyngeal Cancer
    • Pituitary Cancer
    • Rectal Cancer
    • Small Intestine Cancer
    • Spinal Cord Cancer
    • Stomach (Gastric) Cancer
    • Thymus Cancer
  • Hematology-Oncology
    • Classical (Non-Malignant) Hematology Program

Board Certification:

  • Hematology, 1982
  • Hospice and Palliative Medicine, 2012
  • Internal Medicine, 1980
  • Medical Oncology, 1983

Conditions & Treatments:

  • acute leukemia
  • Anal Cancer
  • Anemia
  • anemia - sickle cell
  • anemia - thalassemias
  • bladder (urothelial) cancer
  • Blood Clotting Disorders
  • Blood Disorders
  • bloodless medicine
  • Bone Cancer
  • brain cancer
  • Brain Metastasis
  • Brain Tumors
  • Breast Cancer
  • cancer - multimodal therapy
  • cancer - neuro-oncology
  • cancer - non-surgical treatment
  • cancer pain
  • chronic leukemia
  • Colon Cancer
  • Congenital Anemia
  • cryoglobulinemia
  • decreased platelets
  • Esophageal Cancer
  • Gallbladder Cancer
  • gastrointestinal cancer
  • Gastrointestinal Carcinoid Tumor
  • head/neck malignancies
  • Hemolytic Anemia
  • Hodgkin's lymphoma

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Jefferson Medical College
Residency: Pennsylvania Hospital
Fellowship: Thomas Jefferson University Hospital
Fellowship: Memorial Sloan-Kettering Cancer Center


Alpha Omega Alpha Honor Medical Society, Jefferson Medical College, National American College of Physicians, National American Society of Clinical Oncology, National American Society of Hematology, National Oncology Physicians Network, National


Dr. Mintzer is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Selected Publications:

Raess Philipp W, Mintzer David, Husson Michael, Nakashima Megan O, Morrissette Jennifer J D, Daber Robert, Bagg Adam: BRAF V600E is also seen in unclassifiable splenic B-cell lymphoma/leukemia, a potential mimic of hairy cell leukemia. Blood 122 (17): 3084-5,2013.

Mintzer David M: Oncodoxes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31 (3): 393-4,2013.

Dotan Efrat, Meropol Neal J, Burtness Barbara, Denlinger Crystal S, Lee James, Mintzer David, Zhu Fang, Ruth Karen, Tuttle Holly, Sylvester Judi, Cohen Steven J: A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study. Journal of gastrointestinal cancer 43 (4): 562-9,2012.

Schwartzberg Lee S, Arena Francis P, Mintzer David M, Epperson Amanda L, Walker Mark S: Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer. Clinical breast cancer 12 (2): 87-93,2012.

Granda-Cameron Clara, DeMille Debra, Lynch Mary Pat, Huntzinger Christine, Alcorn Theresa, Levicoff Joan, Roop Carly, Mintzer David: An interdisciplinary approach to manage cancer cachexia. Clinical journal of oncology nursing 14 (1): 72-80,2010.

Mintzer David M, Zheng Sarah, Nagamine Michiko, Newman Jason, Benito Maria: Esthesioneuroblastoma (Olfactory Neuroblastoma) with Ectopic ACTH Syndrome: a multidisciplinary case presentation from the Joan Karnell cancer center of Pennsylvania Hospital. The oncologist 15 (1): 51-8,2010.

Mintzer David M, Billet Shira N, Chmielewski Lauren: Drug-induced hematologic syndromes. Advances in hematology 2009 : 495863,2009.

Borghaei Hossein, Langer Corey J, Millenson Michael, Ruth Karen J, Litwin Samuel, Tuttle Holly, Seldomridge Judie Sylvester, Rovito Marc, Mintzer David, Cohen Roger, Treat Joseph: Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 3 (11): 1286-92,2008.

Academic Contact Info

Pennsylvania Hospital
Abramson Cancer Center at Pennsylvania Hospital
Farm Journal Building
230 West Washington Square, 2nd Floor

Philadelphia, PA 19106
Phone: (215) 829-6088
Fax: (215) 829-6104
Patient appointments: 800-789-PENN (7366)

Related Links